{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:26:08Z","timestamp":1775496368478,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal liver metastases (CRLM) are a major cause of cancer-related deaths. Glucose transporter 1 (GLUT1) is a key mediator of glycolytic metabolism in malignant and immune cells; however, the prognostic relevance of compartment-specific GLUT1 patterns in CRLM remains undefined. We hypothesized that spatial GLUT1 expression at the tumor\u2013liver interface may reflect clinically relevant microenvironmental biology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed data of 192 patients who underwent curative-intent resection for CRLM (75 solitary; 117 multiple). GLUT1 expression was assessed by immunohistochemistry in the tumor tissue (Tu) and infiltration margin (Im) and was correlated with overall survival using Cox regression. Double immunofluorescence for CD8 and GLUT1 was performed for qualitative visualization at the infiltration margin. In an exploratory subset (n\u2009=\u20095), flow cytometry and in vitro killing assays were conducted on GLUT1\u207a versus GLUT1\u207b CD8\u207a tumor-infiltrating lymphocytes (TILs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tumoral GLUT1 correlated with Ki67 (Spearman\u2019s \u03c1\u2009=\u20090.31, p\u2009=\u20090.003) but was not independently associated with overall survival in the main cohort (multivariable HR 1.183, 95% CI 0.74\u20131.90;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.485). In the main cohort, capsule presence remained strongly associated with improved survival (HR 0.35, 95% CI 0.21\u20130.58;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In contrast, high invasive-margin GLUT1 was independently associated with improved survival in the predefined solitary cohort (HR 0.379, 95% CI 0.18\u20130.81;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012). Double immunofluorescence demonstrated the qualitative co-localization of the GLUT1 signal with CD8\u207a cells at the infiltration margin. In exploratory assays (n\u2009=\u20095), flow cytometry suggested GLUT1 enrichment in CD8\u207a terminally differentiated effector memory T cells re-expressing CD45RA (TEMRA), and GLUT1\u207a TIL fractions showed higher in vitro tumor cell killing compared with GLUT1\u207b cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GLUT1 shows compartment- and context-dependent associations in the CRLM. While tumor-core GLUT1 is linked to proliferative activity, invasive-margin GLUT1 is associated with favorable outcomes in solitary metastases. Immunofluorescence and functional data provide hypothesis-generating context and warrant validation with quantitative spatial immune profiling and independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00262-026-04378-z","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:55:29Z","timestamp":1775490929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Compartment-specific GLUT1 patterns in colorectal liver metastases: invasive-margin GLUT1 associates with outcome in solitary disease"],"prefix":"10.1007","volume":"75","author":[{"given":"Eva","family":"Grie\u00dfhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Bogovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Evert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Fichtner-Feigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"4378_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: Globocan estimates. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4378_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00059-X","author":"T Ruers","year":"2002","unstructured":"Ruers T, Bleichrodt R (2002) Treatment of liver metastases, an update. Eur J Cancer. https:\/\/doi.org\/10.1016\/S0959-8049(02)00059-X","journal-title":"Eur J Cancer"},{"key":"4378_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.11.003","author":"A Chiappa","year":"2009","unstructured":"Chiappa A, Makuuchi M, Lygidakis N (2009) The management of colorectal liver metastases. Crit Rev Oncol Hematol. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.11.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"4378_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70330-4","author":"G Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T (2010) Tumour response and secondary resectability. Lancet Oncol. https:\/\/doi.org\/10.1016\/S1470-2045(09)70330-4","journal-title":"Lancet Oncol"},{"key":"4378_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.0833","author":"J Tomlinson","year":"2007","unstructured":"Tomlinson J (2007) Actual 10-year survival after resection. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2007.11.0833","journal-title":"J Clin Oncol"},{"key":"4378_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051424","author":"Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s et al (2005) Effector memory T cells, early metastasis. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa051424","journal-title":"N Engl J Med"},{"key":"4378_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960\u20131964","journal-title":"Science"},{"key":"4378_CR8","first-page":"3491","volume":"58","author":"Y Naito","year":"1998","unstructured":"Naito Y et al (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491\u20133494","journal-title":"Cancer Res"},{"key":"4378_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.017","author":"G Dunn","year":"2004","unstructured":"Dunn G, Old L, Schreiber R (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity. https:\/\/doi.org\/10.1016\/j.immuni.2004.07.017","journal-title":"Immunity"},{"key":"4378_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","volume":"71","author":"M Tosolini","year":"2011","unstructured":"Tosolini M et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71:1263\u20131271","journal-title":"Cancer Res"},{"key":"4378_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","volume":"121","author":"V Ganapathy","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29\u201340","journal-title":"Pharmacol Ther"},{"key":"4378_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E","volume":"83","author":"RS Haber","year":"1998","unstructured":"Haber RS et al (1998) GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83:34\u201340","journal-title":"Cancer"},{"key":"4378_CR13","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1074\/jbc.M010144200","volume":"276","author":"C Chen","year":"2001","unstructured":"Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276:9519\u20139525","journal-title":"J Biol Chem"},{"key":"4378_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-291X(90)91263-R","volume":"170","author":"T Yamamoto","year":"1990","unstructured":"Yamamoto T et al (1990) Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170:223\u2013230","journal-title":"Biochem Biophys Res Commun"},{"key":"4378_CR15","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M (2010) Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab 298:E141-145","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4378_CR16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18090","author":"Feng","year":"2017","unstructured":"Feng et al (2017) Role of glucose metabolism related gene GLUT1. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.18090","journal-title":"Oncotarget"},{"key":"4378_CR17","doi-asserted-by":"publisher","first-page":"43356","DOI":"10.18632\/oncotarget.17445","volume":"8","author":"M Yu","year":"2017","unstructured":"Yu M et al (2017) The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis. Oncotarget 8:43356\u201343367","journal-title":"Oncotarget"},{"key":"4378_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep24129","volume":"6","author":"G Cretenet","year":"2016","unstructured":"Cretenet G et al (2016) Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions. Sci Rep 6:24129","journal-title":"Sci Rep"},{"key":"4378_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69589","author":"Sukumar","year":"2013","unstructured":"Sukumar et al (2013) Inhibiting glycolytic metabolism. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI69589","journal-title":"J Clin Invest"},{"key":"4378_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991\u2013998","journal-title":"Nat Immunol"},{"key":"4378_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12935-018-0715-8","volume":"18","author":"W Tor\u00e9n","year":"2018","unstructured":"Tor\u00e9n W, Ansari D, Andersson R (2018) Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis. Cancer Cell Int 18:217","journal-title":"Cancer Cell Int"},{"key":"4378_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12967-022-03667-2","volume":"20","author":"Y He","year":"2022","unstructured":"He Y et al (2022) Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases. J Transl Med 20:454","journal-title":"J Transl Med"},{"key":"4378_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"Y-R Yu","year":"2020","unstructured":"Yu Y-R et al (2020) Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nat Immunol 21:1540\u20131551","journal-title":"Nat Immunol"},{"key":"4378_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55185","volume":"9","author":"AR Lim","year":"2020","unstructured":"Lim AR, Rathmell WK, Rathmell JC (2020) The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy. Elife 9:e55185","journal-title":"Elife"},{"key":"4378_CR25","doi-asserted-by":"publisher","first-page":"pkab026","DOI":"10.1093\/jncics\/pkab026","volume":"5","author":"DJ H\u00f6ppener","year":"2021","unstructured":"H\u00f6ppener DJ et al (2021) Histopathological growth patterns and survival after resection of colorectal liver metastasis: an external validation study. JNCI Cancer Spectr 5:pkab026","journal-title":"JNCI Cancer Spectr"},{"key":"4378_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6280347","volume":"2019","author":"RC Oliveira","year":"2019","unstructured":"Oliveira RC, Alexandrino H, Cipriano MA, Tralh\u00e3o JG (2019) Liver metastases and histological growth patterns: biological behavior and potential clinical implications\u2014another path to individualized medicine? J Oncol 2019:1\u20136","journal-title":"J Oncol"},{"key":"4378_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5324-y","author":"Z Luo","year":"2019","unstructured":"Luo Z, Zhu M, Zhang Z (2019) Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-019-5324-y","journal-title":"BMC Cancer"},{"key":"4378_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"P-C Ho","year":"2015","unstructured":"Ho P-C et al (2015) Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162:1217\u20131228","journal-title":"Cell"},{"key":"4378_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aap9520","volume":"4","author":"LF Gemta","year":"2019","unstructured":"Gemta LF et al (2019) Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells. Sci Immunol 4:eaap9520","journal-title":"Sci Immunol"},{"key":"4378_CR30","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang C-H et al (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229\u20131241","journal-title":"Cell"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04378-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:55:30Z","timestamp":1775490930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04378-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04378-z","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the University of Regensburg (reference number: 12-101-0009). Written informed consent was obtained from all participants before they were included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"135"}}